Mark Mchale
Chief Scientific Officer at Oak Hill Bio | United Kingdom
Mark Mchale’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Chief Scientific Officer at Oak Hill Bio in January 2022 - Present
Chief Operating Officer at TheraMyc Limited in June 2020 - January 2022
Head R&D, Chief Development Officer at ASLAN Pharmaceuticals Singapore in February 2019 - June 2020
Chief Operating Officer at ASLAN Pharmaceuticals in February 2014 - June 2020
Chief Scientific Officer at ASLAN Pharmaceuticals in February 2011 - June 2020
siRNA Inhalation Delivery Project Leader at AstraZeneca in June 2009 - February 2011
AZ/ Dynavax TLR9 Collaboration Leader at AstraZeneca in May 2007 - February 2011
Senior Project Leader at AstraZeneca R&D in January 2007 - February 2011
Head Molecular Sciences Respiratory and Inflammation at AstraZeneca in January 2001 - January 2009
Team Leader Respiratory and Inflammation at AstraZeneca in June 1997 - September 2001
Senior Scientist Neuroscience at SmithKline Beecham in April 1994 - June 1997
Senior Scientist Biotechnology at SmithKline Beecham in January 1991 - January 1994
Post Doctoral Research Fellow at Professor Sydney Brenner Molecular Genetics Unit Cambridge UK in January 1992 - June 1993
Post Doctoral Research Fellow with Professor Richard Oliver at University of East Anglia in March 1990 - January 1991
PhD with Professor Richard Oliver at University of East Anglia in January 1986 - January 1989
University of London, January 1983 to January 1986
University of East Anglia, January 1986 to January 1989
VP of Corporate Development, Co-founder at Oak Hill Bio
Equities at Athanor Capital
(September 2026 – September 2026)
Program Management
Associate Director, Development Program Management at Regeneron
(September 2026 – September 2026)
Finance Analyst
Accounts Payable Specialist at Oak Hill Bio
(November 2022 – Present)
CTA at Oak Hill Bio
CTA at Oak Hill Bio
(January 2024 – Present)
Group Finance Director at Oak Hill Bio
Snr. Dir. Finance And Operations at Gossamer Bio
(September 2026 – September 2026)
Associate Director, Clinical Operations
Clinical Trial Manager at Johnson & Johnson
(September 2026 – September 2026)
What is Mark Mchale email address?
Email Mark Mchale at [email protected], [email protected] and [email protected]. This email is the most updated Mark Mchale's email found in 2026.
How to contact Mark Mchale?
To contact Mark Mchale send an email to [email protected], [email protected] or [email protected].
What company does Mark Mchale work for?
Mark Mchale works for Oak Hill Bio.
What is Mark Mchale's role at Oak Hill Bio?
Mark Mchale is Chief Scientific Officer
What industry does Mark Mchale work in?
Mark Mchale works in the Pharmaceuticals industry.
